Recursion Pharmaceuticals Inc (RXRX)

02:12 AM

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought - AOL

02:12 AM

03:29 AM

Proficio Capital Partners LLC Makes New $163,000 Investment in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) - Defense World

03:29 AM

Mar 12, 2025

Recursion Pharmaceuticals: Stretched Thin And Chasing Unicorns - Seeking Alpha

Mar 12, 2025

Mar 12, 2025

Jim Cramer on Recursion Pharmaceuticals, Inc. (RXRX): ‘We’re Going To Have To Hold Off’ - Insider Monkey

Mar 12, 2025

Mar 10, 2025

Recursion Pharma Gets A Price-Target Cut After Q4 Miss: Retail Bearish Even As Cathie Wood's Ark Buys The Dip - MSN

Mar 10, 2025

Mar 10, 2025

Why Recursion Pharmaceuticals Stock Is Sinking Today - Yahoo Finance

Mar 10, 2025

Mar 09, 2025

Jim Cramer’s Latest Lightning Round: 8 Stocks in Focus - Insider Monkey

Mar 09, 2025

Mar 08, 2025

Is This Beaten-Down Artificial Intelligence (AI) Stock a Buy? - Nasdaq

Mar 08, 2025

Mar 08, 2025

Cathie Wood-Led Ark Invest Roblox, Roku, UiPath As Markets Take A Dip - Benzinga

Mar 08, 2025

Mar 08, 2025

QRG Capital Management Inc. Grows Holdings in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) - Defense World

Mar 08, 2025

Mar 07, 2025

This Is What Whales Are Betting On Recursion Pharmaceuticals - Benzinga

Mar 07, 2025

Mar 07, 2025

Private Advisor Group LLC Increases Stake in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) - Defense World

Mar 07, 2025

Mar 07, 2025

4 Things You Need to Know if You Buy Recursion Pharmaceuticals Stock Today - MSN

Mar 07, 2025

Mar 07, 2025

This Biotech Stock Could Be the Best Investment of the Decade - The Globe and Mail

Mar 07, 2025

Mar 06, 2025

April 25th Options Now Available For Recursion Pharmaceuticals (RXRX) - Nasdaq

Mar 06, 2025

Mar 06, 2025

Down Over 40%, Is Recursion Pharmaceuticals a Buy on the Dip? - MSN

Mar 06, 2025

Mar 06, 2025

IFP Advisors Inc Acquires 7,455 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) - Defense World

Mar 06, 2025

Mar 06, 2025

Recursion Pharmaceuticals (RXRX) Remains Optimistic Despite Q4 Disappointment - TipRanks

Mar 06, 2025

Mar 06, 2025

TechBio Latest News - substack.com

Mar 06, 2025

Mar 05, 2025

How To Trade (RXRX) - Stock Traders Daily

Mar 05, 2025

Mar 05, 2025

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Q4 2024 Earnings Call Transcript - MSN

Mar 05, 2025

Mar 05, 2025

News Flash: Analysts Just Made A Sizeable Upgrade To Their Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Forecasts - Yahoo Finance

Mar 05, 2025

Mar 05, 2025

Recursion Pharmaceuticals Shares Dip Amid Revenue Timing - TipRanks

Mar 05, 2025

Mar 04, 2025

Why Recursion Pharmaceuticals, Inc. (RXRX) Crashed on Monday - MSN

Mar 04, 2025

Mar 04, 2025

Rhumbline Advisers Has $2.26 Million Stock Holdings in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) - Defense World

Mar 04, 2025

Mar 04, 2025

Recursion Pharmaceuticals (NASDAQ:RXRX) Shares Down 5.3% on Disappointing Earnings - Defense World

Mar 04, 2025

Mar 04, 2025

Recursion Pharmaceuticals Inc (RXRX) Q4 2024 Earnings Call Highlights: Strong Financial ... By GuruFocus - Investing.com Canada

Mar 04, 2025

Mar 03, 2025

Recursion Pharmaceuticals projects $100M synergies in 2025 amid advancing pipeline and partnerships - MSN

Mar 03, 2025

Mar 03, 2025

Recursion Pharmaceuticals’ Earnings Call Highlights Growth - TipRanks

Mar 03, 2025

Mar 03, 2025

Recursion Pharmaceuticals (NasdaqGS:RXRX) Surges 6% Following US$500 Million Follow-On Equity Offering - Yahoo Finance

Mar 03, 2025

Mar 03, 2025

Recursion Pharmaceuticals' Update Could Shed Light On Pipeline, Cost-Saving Plans, Analyst Says - Benzinga India

Mar 03, 2025

Mar 03, 2025

Atria Wealth Solutions Inc. Invests $75,000 in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) - Defense World

Mar 03, 2025

Mar 02, 2025

This Just In: Analysts Are Boosting Their Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Outlook for This Year - Simply Wall St

Mar 02, 2025

Mar 02, 2025

Recursion Pharmaceuticals (NASDAQ:RXRX) Shares Gap Down After Earnings Miss - Defense World

Mar 02, 2025

Mar 02, 2025

Recursion Pharmaceuticals Stock Scores RS Ratings Over 90 - MSN

Mar 02, 2025

Mar 01, 2025

AI Drug Firm Recursion Wants to Be the Amazon Prime of Pharma - Advisor Perspectives

Mar 01, 2025

Mar 01, 2025

Cathie Wood's Ark Invest Loads Up On Tempus AI, Archer Aviation, But Sells Twist Bioscience: Here Are Key Ark Trades This FridayArcher Aviation (NYSE:ACHR), Accolade (NASDAQ:ACCD) - Benzinga

Mar 01, 2025

Mar 01, 2025

Recursion stock holds as Cowen sees merger synergies By Investing.com - Investing.com Canada

Mar 01, 2025

Feb 28, 2025

Recursion Pharmaceuticals Reports Mixed 2024 Financial Results - TipRanks

Feb 28, 2025

Feb 28, 2025

Cathie Wood’s ARK ETF bolsters Tempus AI, Recursion stocks By Investing.com - Investing.com Australia

Feb 28, 2025

Feb 28, 2025

Cathie Wood's ARK ETF bolsters Tempus AI, Recursion stocks - Investing.com

Feb 28, 2025

Feb 28, 2025

Cathie Wood’s ARK ETF bolsters Tempus AI, Recursion stocks - Investing.com India

Feb 28, 2025

Feb 28, 2025

Strong Buy Recommendation for Recursion Pharmaceuticals: Leading Techbio Innovator with Robust Financials and Strategic AI Integration - TipRanks

Feb 28, 2025

Feb 28, 2025

Best Biotech Stocks To Keep An Eye OnFebruary 28th - MarketBeat

Feb 28, 2025

Feb 28, 2025

Recursion Pharmaceuticals (RXRX) Reports Q4 Loss, Lags Revenue Estimates - MSN

Feb 28, 2025

Feb 28, 2025

Recursion Pharmaceuticals misses Q4 estimates, shares dip By Investing.com - Investing.com Australia

Feb 28, 2025

Feb 28, 2025

Recursion Pharmaceuticals misses Q4 estimates, shares dip - Investing.com

Feb 28, 2025